Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology
Disease Category: Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
Trial Information
A pilot trial of ramelteon treatment for insomnia in adults treated with stimulants for Attention Deficit Hyperactivity Disorder
•Are you currently treated for ADHD?
•Do you have trouble falling asleep at night?
The Massachusetts General Hospital Adult ADHD Program is currently conducting a research study looking at the effectiveness and safety of an FDA approved medication for the treatment of insomnia in adults (18-55) with Attention Deficit Hyperactivity Disorder (ADHD). Adults who are currently taking medication for ADHD and experience insomnia may qualify to participate in this study. The study will consist of a screening visit (or visits), four 45 minute-long study visits, and a follow-up visit for a total of about 6 weeks. All study visits and medication will be conducted at no cost to study participants. If you are interested, please call 617-503-1454 or e-mail kpion@partners.org.
Katie Pion
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-503-1454
EMail: kpion@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
